Comparative pharmacokinetics, distributions in tissue, and interactions with blood proteins of conventional and sterically stabilized liposomes containing 2′,3′-dideoxyinosine

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 1, 1996, Pages 225-229

  Harvie, Pierrot ^a   Désormeaux, André ^a   Bergeron, Marie Claude ^a   Tremblay, Michel ^a   Beauchamp, Denis ^a   Poulin, Louise ^a   Bergeron, Michel G ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; LIPOSOME;

ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ARTICLE; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG HALF LIFE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIVIRAL AGENTS; BLOOD PROTEINS; DIDANOSINE; DRUG INTERACTIONS; DRUG STABILITY; FEMALE; INJECTIONS, INTRAVENOUS; LIPOSOMES; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 0030053635     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.1.225     Document Type: Review

References (28)

1. Allen, T. M. 1994 Long-circulating (sterically stabilized) liposomes for targeted drug delivery. Trends Pharmacol. Sci 15:215-220
2. Allen, T. M. 1994. The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system Adv Drug Delivery Rev. 13:285-309
3. Chonn, A., S. C. Semple, and P. R. Cullis. 1992 Association of blood proteins with large unilamellar liposomes in vivo. J Biol. Chem. 267:18759-18765.
4. Cunnolly, K. J., and S. C. Hammer. 1992. Antiretroviral therapy: reverse transcriptase inhibition. Antimicrob. Agents Chemother. 36:245-254
5. De Clercq, E. 1992. HIV inhibitors targeted at the reverse transcriptase AIDS Res Hum. Retroviruses 8:119-121.
6. Désormeaux, A., P. Harvie, S. Perron, B. Makabi-Panzu, D. Beauchamp, M. Tremblay, L. Poulin, and M. G. Bergeron. 1994 Antiviral efficacy. intracellular uptake and tissue distribution of liposome-encapsulated 2′,3′-dideoxyinosine (ddI) in rats. AIDS 8:1545-1553
7. Devine, D. V., K. Wong, K. Serrano, A. Chonn, and P. R. Cullis. 1994 Liposome-complement interactions in rat serum. implications for liposome survival studies. Biochim Biophys. Acta 1191:43-51.
8. Faulds, D., and R. N. Brogden. 1992 Didanosine. a review of its antiviral activity, pharmacokinetic properties and therapeutic potential in human immunodeficiency virus infection. Drugs 44:94-116
9. Gabizon, A., and D. Papahadjopoulos. 1988. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl Acad. Sci USA 85:6949-6953.
10. Gendelman, H. E., J. M. Orenstein, L. M. Baca, B. Weiser, H. Burger, D. C. Kalter, and M. S. Meltzer. 1989. The macrophage in the persistence and pathogenesis of HIV infection. AIDS 3:475-495.
11. Gregoriadis, G. 1991. Overview of liposomes J. Antimicrob. Chemother. 28:39-48.
12. Harvie, P., A. Dësormeaux, N. Gagné, M. Tremblay, L. Poulin, D. Beauchamp, and M. G. Bergeron. 1995 Lymphoid tissues targeting of liposome-encapsulated 2′,3′-dideoxyinosine (ddI). AIDS 9:701-707.
13. Klibanov, A. K., K. Maruyama, V. P. Torchilin, and L. Huang. 1990. Amphipathic polyethylene glycols effectively prolong the circulation time of liposomes. FEBS Lett 268:235-237.
14. Lasic, D. D., F. J. Martin, A. Gabizon, S. K. Huang, and D. Papahadjopoulos. 1991. Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. Biochim. Biophys. Acta 1070:187-192.
15. Loughrey, H. C., M. B. Bally, L. W. Reinish, and P. R. Cullis. 1990. The binding of phosphatidylglycerol to rats is mediated by complement. Thromb. Haemostasis 64:172-180.
16. McCormack, B., and G. Gregoriadis. 1994. Drugs-in-cyclodextrins-in liposomes: a novel concept in drug delivery. Int. J. Pharm. 112:249-258.
17. Meltzer, M. S., D. R. Skillman, P. J. Gomatos, D. C. Kalter, and H. E. Gendelman. 1990. Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection. Annu. Rev. Immunol. 8:169-194.
18. Mitsuya, H., R. F. Jarrett, M. Matsukura, F. Di Marzo Veronese, A. De Vico, M. G. Sarngadharan, D. G. Johns, M. S. Reitz, and S. Broder. 1987. Longterm inhibition of human T-lymphotropic virus type III/lymphoadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2′-3′-dideoxynucleosides in vitro. Proc. Natl. Acad. Sci USA 84:2033-2037
19. Nordback, I. H., J. L. Olson, R. E. Chaisson, and J. L. Cameron. 1992. Acute effects of a nucleoside analog dideoxyinosine (ddI) on the pancreas. J Surg. Res. 53:610-614.
20. Patel, H. M. 1992. Serum opsonins and liposomes. Their interaction and opsonophagocytosis. Crit. Rev Ther. Drug Carrier Syst 9:39-90.
21. Rahman, Y. E., E. A. Cerny, K. R. Patel, E. H. Lau, and B. J. Wright. 1982. Differential uptake of liposomes varying in size and lipid composition by parenchymal and Kupffer cells of mouse liver. Life Sci. 31:2061-2071.
22. Ray, G. F., W. D. Mason, and M. Z. Badr. 1990. Pharmacokinetics of the anti-AIDS drug 2′,3′-dideoxyinosine in the rat. Drug Metab. Dispos. 18:654-658.
23. Roerdink, F., J. Dijkstra, G. Hartman, B. Bolscher, and G. Scherphof. 1981. The involvement of parenchymal, Kupffer and endothelial liver cells in the hepatic uptake of intravenously injected liposomes. Effects of lanthanum and gadolinium salts. Biochim. Biophys. Acta 677:79-89.
24. Senior, J. H. 1987. Fate and behavior of liposomes in vivo: a review of controlling factors Crit. Rev Ther. Drug Carrier Syst. 3:123-193.
25. Shelton, M. J., A. M. O'Donnell, and G. D. Morse. 1992 Didanosine. Ann. Pharmacother 26:660-670.
26. Woodle, M. C. 1993. Surface-modified liposomes: assessment and characterization for increased stability and prolonged blood circulation Chem. Phys. Lipids 64:249-262.
27. Woodle, M. C., and D. D. Lasic. 1992. Sterically stabilized liposomes. Biochim. Biophys Acta 1113:171-199
28. Yarchoan, R., J. M. Pluda, R. V. Thomas, H. Mitsuya, P. Brouwers, K. M. Wyvill, N. Hartman, D. G. Johns, and S. Broder. 1990. Long-term toxicity/ activity profile of 2′,3′-dideoxyinosine in AIDS or AIDS-related complex. Lancet 336:526-529.